Corbion NV

Corbion NV, based in the Netherlands, specializes in biobased ingredients that enhance food preservation and nutritional value, catering to a diverse range of markets including food, pharmaceuticals, and personal care. Founded in 1903 in Amsterdam, Netherlands, Corbion NV focuses on biobased solutions. The company has evolved to meet growing sustainability demands, with a diverse portfolio that extends globally. Key figures involved include founders Angelina Aguilar and Steffen Lutz, with Dirk Förster and Olivier Rigaud playing significant roles in leadership.

Corbion specializes in innovative biobased ingredients and solutions designed to enhance food preservation, nutritional value, and overall functionality across a broad array of markets. Their flagship products include AlgaPrime™ DHA, a sustainable algae-derived omega-3 fatty acid that serves as an alternative to fish oil, and the Corbion Natural Mold Inhibition Model (CNMIM), a predictive tool for mold growth in pan breads. These products cater to diverse end-users, including manufacturers in food and beverage, pharmaceuticals, and personal care industries. Corbion's offerings aim to address various challenges such as reducing saturated fat content, extending shelf life, and promoting food safety.

The company serves a global client base, with products distributed in North America, Europe, Asia, and other regions, ensuring they meet the evolving demands of health-conscious consumers and regulatory standards. In 2023, Corbion reported a revenue of USD 1,562. 76 mn and an EBITDA of USD 218. 43 mn.

The company's revenue is generated through a combination of direct sales and partnerships with manufacturers in various industries, primarily through B2B transactions. The firm’s commercial model involves long-term contracts and supply agreements, allowing clients to access essential ingredients that enhance product quality and safety.